Breaking News Instant updates and real-time market news.

MRK

Merck

$62.51

0.85 (1.38%)

08:30
10/14/16
10/14
08:30
10/14/16
08:30

Merck announces launch of Biosimilars Clarified website

Merck announced the launch of Biosimilars Clarified, a new educational website for patients, caregivers and the healthcare community that is designed to provide clear, concise and straightforward information about biosimilar medicines.

  • 25

    Oct

  • 26

    Oct

  • 06

    Nov

MRK Merck
$62.51

0.85 (1.38%)

10/10/16
LEER
10/10/16
NO CHANGE
LEER
Market Perform
Merck 'steals the show' at ESMO with Keytruda data, says Leerink
Leerink analyst Seamus Fernandez said Merck (MRK) stole the show at ESMO with its Keytruda data and he continues to think the company will dominate first line lung cancer treatment for years to come in patients with 50%+ PDL1 expression. Additionally, he expects Merck to gain additional traction in the overall market, noting that confirmation that Keytruda is benefiting patients when combined with Alimta/carboplatin with Alimta maintenance raises the possibility Merck could compete broadly in the overall non-squamous patient population. However, Fernandez keeps a Market Perform rating on Merck, as he thinks its current valuation largely reflects improved growth prospects through 2020.
10/10/16
JMPS
10/10/16
NO CHANGE
JMPS
Incyte treatment looking 'promising,' says JMP Securities
After reviewing recent data, JMP Securities analyst Liisa Bayko says that the combination of Incyte's (INCY) Epacadostat plus Merck's (MRK) Keytruda is "emerging as a promising treatment, potentially even best in class." The analyst says that the progression free survival rate of the combination in melanoma patients "is emerging to be quite competitive," while the efficacy rate in other solid tumors "seemed encouraging." The analyst raised her price target on Incyte to $110 from $100 and keeps an Outperform rating on the stock.
10/13/16
BOFA
10/13/16
UPGRADE
Target $70
BOFA
Buy
Merck upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Colin Bristow upgraded Merck to Buy and raised its price target to $70 from $57 to reflect its opportunity in first line lung cancer. Bristow significantly raised his Keytruda sales estmate to 7.5B from $5.5B following Merck's first line lung cancer data presentations at ESMO over the weekend and feedback from experts. He expects Keytruda to receive early approval/launch in first line NSCLC from the December 24 PDUFA and to become the standard of care in the identified label and further upside from chemo combo.
10/13/16
10/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Merck (MRK) upgraded to Buy from Neutral at BofA/Merrill with analyst Colin Bristow citing its opportunity in first line lung cancer. 2. Viacom (VIA, VIAB) upgraded to Market Perform from Underperform at Wells Fargo and to Buy from Underperform at BofA/Merrill. 3. TD Ameritrade (AMTD) and Charles Schwab (SCHW) were upgraded to Buy from Neutral at BofA/Merrill. 4. Talend (TLND) upgraded to Buy from Neutral at Goldman with analyst Jesse Hulsing saying the company will benefit from analytic workloads moving to the cloud. 5. CSC (CSC) upgraded to Buy from Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

VLGEA

Village Super Market

$24.36

0.35 (1.46%)

16:25
09/25/17
09/25
16:25
09/25/17
16:25
Hot Stocks
Village Super Market CEO James Sumas to step down »

Village Super Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNCA

Genocea

$5.33

0.04 (0.76%)

16:25
09/25/17
09/25
16:25
09/25/17
16:25
Hot Stocks
Breaking Hot Stocks news story on Genocea »

Genocea trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AAPL

Apple

$150.55

-1.34 (-0.88%)

, DGX

Quest Diagnostics

$94.57

-7.54 (-7.38%)

16:23
09/25/17
09/25
16:23
09/25/17
16:23
General news
On The Fly: Top stock stories for Monday »

Stocks began the session…

AAPL

Apple

$150.55

-1.34 (-0.88%)

DGX

Quest Diagnostics

$94.57

-7.54 (-7.38%)

LH

LabCorp

$150.32

-4.75 (-3.06%)

TGT

Target

$58.55

-0.44 (-0.75%)

AIG

AIG

$61.01

0.3 (0.49%)

NAV

Navistar

$42.14

0.81 (1.96%)

VLKAY

Volkswagen

$33.96

-0.61 (-1.76%)

FINL

Finish Line

$10.49

0.76 (7.81%)

NE

Noble Corp.

$4.45

0.32 (7.75%)

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

S

Sprint

$7.82

-0.7 (-8.22%)

SFTBF

SoftBank

$79.96

-2.7 (-3.27%)

TMUS

T-Mobile

$62.89

-1.17 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 02

    Oct

  • 22

    Oct

  • 30

    Oct

  • 30

    Nov

  • 16

    May

FN

Fabrinet

$34.78

-1.17 (-3.25%)

, SANM

Sanmina

$36.00

-1.3 (-3.49%)

16:22
09/25/17
09/25
16:22
09/25/17
16:22
Hot Stocks
Fabrinet names Seamus Grady CEO »

Fabrinet (FN) announced…

FN

Fabrinet

$34.78

-1.17 (-3.25%)

SANM

Sanmina

$36.00

-1.3 (-3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

SNX

Synnex

$116.50

0.4 (0.34%)

16:22
09/25/17
09/25
16:22
09/25/17
16:22
Hot Stocks
Breaking Hot Stocks news story on Synnex »

Synnex up 11% to $130.02…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

GFN

General Finance Corp

$4.95

-0.1 (-1.98%)

16:21
09/25/17
09/25
16:21
09/25/17
16:21
Hot Stocks
General Finance Corp announces funding for certain acquisition »

General Finance announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEX

Kirby

$64.35

0.35 (0.55%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Hot Stocks
Breaking Hot Stocks news story on Kirby »

Hushang Ansary reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SNWV

Sanuwave Health

$0.14

0.015 (12.50%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Conference/Events
Sanuwave Health to host business news update conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKY

Parkway

$23.00

-0.02 (-0.09%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Hot Stocks
Parkway announces special cash dividend of $4.00 per share »

Parkway announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CQP

Cheniere Energy Partners

$27.40

0.37 (1.37%)

16:19
09/25/17
09/25
16:19
09/25/17
16:19
Initiation
Cheniere Energy Partners initiated  »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:19
09/25/17
09/25
16:19
09/25/17
16:19
Hot Stocks
Red Hat reports Q1 subscription revenue up 14% in constant currency »

Subscription revenue from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PKY

Parkway

$23.00

-0.02 (-0.09%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Hot Stocks
Parkway says shareholders approve merger with affiliate of CPPIB »

Parkway announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

LNG

Cheniere Energy

$44.08

0.6 (1.38%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Earnings
Red Hat raises FY18 adjusted EPS view to $2.77-$2.79 from $2.66-$2.70 »

Consensus $2.69. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Earnings
Red Hat sees Q3 adjusted EPS roughly 70c, consensus 70c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CRAY

Cray

$18.13

-0.475 (-2.55%)

, STX

Seagate

$33.16

-0.41 (-1.22%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Hot Stocks
Cray finishes strategic transaction of Seagate's ClusterStor business »

Cray (CRAY) announced it…

CRAY

Cray

$18.13

-0.475 (-2.55%)

STX

Seagate

$33.16

-0.41 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNX

Synnex

$116.50

0.4 (0.34%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Hot Stocks
SYNNEX raises quarterly dividend 20% to 30c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

$NSD

NASDAQ Market Internals

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNX

Synnex

$116.50

0.4 (0.34%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Earnings
SYNNEX sees Q4 adjusted EPS $2.63-$2.73, consensus $2.49 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

RHT

Red Hat

$105.73

-0.57 (-0.54%)

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Earnings
Red Hat reports Q2 adjusted EPS 77c, consensus 67c »

Reports Q2 revenue $723M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SNX

Synnex

$116.59

0.485 (0.42%)

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Hot Stocks
Breaking Hot Stocks news story on Synnex »

SYNNEX raises quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

$NYE

NYSE Market Internals

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVTY

Invuity

$7.80

-0.5 (-6.02%)

16:15
09/25/17
09/25
16:15
09/25/17
16:15
Hot Stocks
Invuity announces commercial launch of PhotonBlade »

Invuit announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Nov

SNX

Synnex

$116.59

0.485 (0.42%)

16:15
09/25/17
09/25
16:15
09/25/17
16:15
Earnings
Synnex reports Q3 adjusted EPS $2.16, consensus $1.97 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

KDMN

Kadmon

$3.83

0.31 (8.81%)

16:13
09/25/17
09/25
16:13
09/25/17
16:13
Syndicate
Kadmon files to sell common stock and warrants »

Kadmon announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.